INmune Bio Correlations

INMB Stock  USD 1.73  0.10  6.13%   
The current 90-days correlation between INmune Bio and CEL SCI Corp is 0.22 (i.e., Modest diversification). The correlation of INmune Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

INmune Bio Correlation With Market

Modest diversification

The correlation between INmune Bio and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and DJI in the same portfolio, assuming nothing else is changed.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INmune Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.

Moving together with INmune Stock

  0.69KTTAW Pasithea TherapeuticsPairCorr

Moving against INmune Stock

  0.53VCEL Vericel Corp OrdPairCorr
  0.45DVAX Dynavax TechnologiesPairCorr
  0.41SABSW SAB BiotherapeuticsPairCorr
  0.53300238 Guanhao BiotechPairCorr
  0.38ALA Arovella TherapeuticsPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FGENTPST
TPSTBRNS
SKYETPST
BRNSCVM
SKYECVM
TPSTCVM
  

High negative correlations

FGENMRSN
MRSNTPST
SKYEMRSN
XFORCVM
MRSNCVM
MRSNBRNS

Risk-Adjusted Indicators

There is a big difference between INmune Stock performing well and INmune Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze INmune Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CVM  4.35 (0.98) 0.00 (0.49) 0.00 
 6.78 
 25.92 
BRNS  3.20 (0.94) 0.00 (0.86) 0.00 
 5.71 
 24.01 
ALGS  4.62 (0.13) 0.00  0.81  0.00 
 10.16 
 28.43 
TPST  4.55 (1.84) 0.00 (2.50) 0.00 
 4.70 
 57.69 
OKUR  4.06  0.05  0.02  0.13  4.36 
 9.79 
 23.27 
MRSN  7.16  3.09  0.82  0.77  2.27 
 7.25 
 210.61 
SKYE  4.82 (0.59) 0.00 (0.32) 0.00 
 10.19 
 24.11 
XFOR  3.60  0.26  0.09  0.21  3.78 
 9.63 
 36.44 
PDSB  4.08 (0.08) 0.01  0.06  4.59 
 8.60 
 27.78 
FGEN  2.67 (0.17) 0.00  0.43  0.00 
 4.33 
 28.75 

INmune Bio Corporate Management

Christopher BarnumHead NeuroscienceProfile
BSc FRCPathChief OfficerProfile
Mark LowdellChief OfficerProfile
Daniel CarlsonHead RelationsProfile
Raymond MDPresident, CoFounderProfile
Joshua EsqGeneral CounselProfile